Literature DB >> 6745922

Exclusion of chromosomal mosaicism in prenatal diagnosis.

U Claussen, H Schäfer, H J Trampisch.   

Abstract

For use in prenatal diagnosis, tables were prepared giving the number of metaphases or clones, respectively, which must be analysed in order to detect fetal mosaicism of a given degree (= percentage of the aberrant cell population) or higher with at least 95% or 99% probability. Different tables are provided for the two techniques of chromosomal preparation: the colony method and the flask method.

Mesh：

Year:  1984        PMID： 6745922     DOI： 10.1007/BF00270553

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  7 in total

1.  Cytogenetical problems in prenatal diagnosis.

Authors:  W Schmid
Journal:  Hereditas       Date:  1977       Impact factor: 3.271

2.  Comparison of cell cycle time in normal and trisomic cells.

Authors:  G R Paton; M F Silver; A C Allison
Journal:  Humangenetik       Date:  1974

3.  Population cytogenetic investigation of newborns in Moscow.

Authors:  N P Bochkov; N P Kuleshov; A N Chebotarev; V I Alekhin; S A Midian
Journal:  Humangenetik       Date:  1974-05-17

4.  A modified method of culturing human amniotic fluid cells for prenatal detection of genetic disorders.

Authors:  H Knörr-Gärtner; I Härle
Journal:  Humangenetik       Date:  1972

5.  Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use.

Authors:  E B Hook
Journal:  Am J Hum Genet       Date:  1977-01       Impact factor: 11.025

6.  The pipette method: a new rapid technique for chromosome analysis in prenatal diagnosis.

Authors:  U Claussen
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

7.  [Prenatal genetic diagnosis. Report on 150 cases investigated in Zurich (author's transl)].

Authors:  W Schmid
Journal:  Schweiz Rundsch Med Prax       Date:  1975-05-20
  7 in total
  2 in total

1.  Sequential sampling in clinical cytogenetics: a quality control viewpoint.

Authors:  M A De Arce; S P McManus
Journal:  J Med Genet       Date:  1988-09       Impact factor: 6.318

2.  Derivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applications.

Authors:  Shelly E Tannenbaum; Tikva Tako Turetsky; Orna Singer; Einat Aizenman; Sophie Kirshberg; Nili Ilouz; Yaniv Gil; Yael Berman-Zaken; Temima Schnitzer Perlman; Nitshia Geva; Ora Levy; Daniel Arbell; Alex Simon; Assaf Ben-Meir; Yoel Shufaro; Neri Laufer; Benjamin E Reubinoff
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.